S
Savino Cilla
Researcher at Catholic University of the Sacred Heart
Publications - 9
Citations - 143
Savino Cilla is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Radiosurgery & Acute toxicity. The author has an hindex of 8, co-authored 9 publications receiving 125 citations. Previous affiliations of Savino Cilla include The Catholic University of America & Istituto Nazionale di Fisica Nucleare.
Papers
More filters
Journal Article
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial
Mariangela Massaccesi,Savino Cilla,Francesco Deodato,Cinzia Digesù,Gabriella Macchia,Luciana Caravatta,Edy Ippolito,Vincenzo Picardi,Marica Ferro,S. Mignogna,Gian Carlo Mattiucci,Vincenzo Valentini,Angelo Piermattei,Alessio G. Morganti +13 more
TL;DR: After radical prostatectomy, hypofractionated high-dose SIB-IMRT enables for reduction of the overall treatment time, with an acute toxicity profile which compares favourably with that of conventionally fractionated high -dose three-dimensional conformal radiotherapy (3D-CRT).
Journal ArticleDOI
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases
Savino Cilla,Francesco Deodato,Cinzia Digesù,Gabriella Macchia,Vincenzo Picardi,Milena Ferro,Giuseppina Sallustio,Marco De Spirito,Angelo Piermattei,Alessio G. Morganti +9 more
TL;DR: SIB-VMAT plans showed a high level of fluence modulation needed for SIB treatments, high conformal dose distribution, similar target coverage, and a tendency to improve OARs sparing compared with the benchmark SIB-IMRT plans.
Journal ArticleDOI
Stereotactic Radiosurgery (SRS) with Volumetric Modulated Arc Therapy (VMAT): Interim Results of a Multi-arm Phase I Trial (DESTROY-2)
Francesco Deodato,Savino Cilla,Gabriella Macchia,Gabriella Torre,Luciana Caravatta,G.A. Mariano,S. Mignogna,Milena Ferro,Gian Carlo Mattiucci,Mario Balducci,Vincenzo Frascino,Angelo Piermattei,Gabriella Ferrandina,Vincenzo Valentini,Alessio G. Morganti +14 more
TL;DR: SRS-VMAT resulted in positive early clinical results in terms of tumour response, local control rate and acute toxicity, and the maximum tolerable dose has not yet been reached in any study arm.
Journal ArticleDOI
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: Feasibility and clinical results
Gabriella Macchia,Francesco Deodato,Savino Cilla,Gabriella Torre,Giacomo Corrado,Francesco Legge,Maria Antonietta Gambacorta,Luca Tagliaferri,S. Mignogna,Giovanni Scambia,Vincenzo Valentini,Alessio G. Morganti,Gabriella Ferrandina +12 more
TL;DR: Although the maximum tolerated dose was not reached, SRS-VMAT resulted in positive early clinical results in terms of tumor response, local control rate and toxicity.
Journal ArticleDOI
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial
Edy Ippolito,Numa Cellini,Cinzia Digesù,Savino Cilla,Giovanna Mantini,Mario Balducci,Alessandra Di Lallo,Francesco Deodato,Gabriella Macchia,Mariangela Massaccesi,Gian Carlo Mattiucci,Luca Tagliaferri,Angelo Piermattei,Daniele Cuscunà,Alessio G. Morganti +14 more
TL;DR: Postoperative hypofractionated IMRT SIB for prostate cancer seemed to be well tolerated and could be tested in phase II studies.